About
Cell-specific genetic medicines
Nuntius Therapeutics is a Y Combinator company (Winter 2021). YC-listed status: Active.
- Location
- London, England, United Kingdom
- Added via
- web
- Ownership
- unclaimed
Products
- Nuntius Therapeutics — Biotech platform developing programmable nanocarrier delivery systems and engineered mRNA therapeutics targeting cancer, lung, and neurodegenerative diseases. · Other
← Directory